Revealing Potent & Selective Human Prostaglandin F (FP) Receptor Antagonist BAY-6672 for Idiopathic Pulmonary Fibrosis (IPF)

Time: 4:30 pm
day: Day One


  • Antagonism of the FP Receptor as a promising new antifibrotic target for the treatment of IPF
  • From screening hit to BAY-6672: a successful multifactorial small molecule optimization story
  • BAY-6672 is now available as donated chemical probe via the Structural Genomics Consortium (SGC